Skip to content

Clinical trials

Withdrawn Phase 2 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Status: Withdrawn Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20131
20144
20161
20172
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhejiang University3
Columbia University1
Emory University1
European Organisation for Research and Treatment of Cancer - EORTC1
M.D. Anderson Cancer Center1
National Cancer Institute (NCI)1
Pinnacle Biologics Inc.1
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1
University of Florida1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms14
Esophageal Squamous Cell Carcinoma3
Carcinoma, Non-Small-Cell Lung2
Biliary Tract Neoplasms1
Breast Neoplasms1
Deglutition Disorders1
Dermatitis, Phototoxic1
Endophthalmitis1
Head and Neck Neoplasms1
Lacerations1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.